Clinical and Experimental Hepatology

Abstract

4/2025 vol. 11
Review paper

Metabolic dysfunction-associated steatotic liver disease in children

  1. Department of Infectious Diseases and Hepatology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland
Clin Exp HEPATOL 2025; 11, 4: 333–336
Online publish date: 2025/10/21
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the main chronic liver pathology in children and adolescents. The incidence of MASLD is increasing with the obesity pandemic; MASLD affects approximately 40% of obese children. The article presents diagnostic criteria for MASLD in children, studies of potential screening markers and suggestions for treatment procedures.
Share